findmyKOL
Clinical trialNCT00390013TerminatedInterventional

To Evaluate if the Medication Gabapentin Lessens Vulvar Pain

SponsorColleen StockdaleEnrollment9Vulvar Pain SymptomsVulvodynia (Chronic Vulvar Pain)
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The purpose of this research study is to evaluate if the medication gabapentin lessens the vulvar pain some women experience.
clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

  • Colleen Kennedy Stockdale, M.D., M.S.

    University of Iowa Hospital and Clinics, Department of Ob/Gyn

    Principal Investigator
    clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • University of Iowa Hospital and Clinics

    Iowa City, Iowa, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Gabapentin →Placebo
Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
31 Jan 2007
Primary completion
31 Mar 2008
Completion
31 Mar 2008
Last update posted
31 Jul 2017
Registered enrollment
9
Registry id
NCT00390013
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.